2. Academic Validation
  3. Synthesis of functionalized 1,8-naphthyridinones and their evaluation as novel, orally active CB1 receptor inverse agonists

Synthesis of functionalized 1,8-naphthyridinones and their evaluation as novel, orally active CB1 receptor inverse agonists

  • Bioorg Med Chem Lett. 2006 Feb;16(3):681-5. doi: 10.1016/j.bmcl.2005.10.028.
John S Debenham 1,  Christina B Madsen-Duggan,  Thomas F Walsh,  Junying Wang,  Xinchun Tong,  George A Doss,  Julie Lao,  Tung M Fong,  Marie-Therese Schaeffer,  Jing Chen Xiao,  Cathy R-R C Huang,  Chun-Pyn Shen,  Yue Feng,  Donald J Marsh,  D Sloan Stribling,  Lauren P Shearman,  Alison M Strack,  D Euan MacIntyre,  Lex H T Van der Ploeg,  Mark T Goulet
Affiliations

Affiliation

  • 1 Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 2000, Rahway, NJ 07065, USA. john_debenham@merck.com
PMID: 16263284 DOI: 10.1016/j.bmcl.2005.10.028
Abstract

Synthesis, SAR, and binding affinities are described for a new class of 1,8-naphthyridinone CB1 receptor specific inverse agonists. Food intake, knockout mouse, and pharmacokinetic evaluation of 14 indicate that this compound is an effective orally active modulator of CB1.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z